Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 80255 BALTIMORE, MD
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$105,598,291
+$42,888,247 QoQ
Shares Held
5,748,410
+79.3% QoQ
Ownership
5.07%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 215 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. VRDN ranks #46 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in VRDN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $105,598,291 5,748,410
2026-03-31 $62,710,044 3,206,035
2025-12-31 $107,034,563 3,439,414
2025-09-30 $52,182,684 2,418,104
2025-06-30 $40,475,804 2,895,265
2025-03-31 $22,755,978 1,688,129
2024-12-31 $25,434,966 1,326,811
2024-09-30 $1,024,023 45,012
2024-06-30 $577,891 44,419
2024-03-31 $549,271 31,369
2023-12-31 $564,973 25,940
2023-09-30 $406,893 26,525
2023-06-30 $569,651 23,945
2023-03-31 $576,444 22,659
2022-12-31 $727,153 24,894
2022-09-30 $360,032 17,554